380
Views
18
CrossRef citations to date
0
Altmetric
Original

apoA- AND apoB-CONTAINING LIPOPROTEINS AND Lp(A) CONCENTRATION IN NON-DIALYZED PATIENTS WITH CHRONIC RENAL FAILURE

, Ph.D. & , Ph.D.
Pages 485-492 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bengt Fellström, Hallvard Holdaas, Alan G. Jardine, Maria K. Svensson, Mattis Gottlow, Roland E. Schmieder & Faiez Zannad. (2009) Cardiovascular disease in patients with renal disease: the role of statins. Current Medical Research and Opinion 25:1, pages 271-285.
Read now
Elżbieta Kimak, Janusz Solski, Iwona Baranowicz-Gąszczyk & Andrzej Książek. (2006) A Long-Term Study of Dyslipidemia and Dyslipoproteinemia in Stable Post-Renal Transplant Patients. Renal Failure 28:6, pages 483-486.
Read now

Articles from other publishers (16)

Wenbo Zhao, Junqing Li, Xiaohao Zhang, Xiaomei Zhou, Junyi Xu, Xun Liu & Zifeng Liu. (2020) Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey. Lipids in Health and Disease 19:1.
Crossref
Sandeep P, Aparna R. Bitla, G. Sarvari, SrinivasaRao PVLN, N. HariniDevi & Siva Kumar V. (2018) Assessment of cardiovascular risk in patients with chronic kidney disease –A study from a tertiary care centre in south India. Journal of Indian College of Cardiology 8:4, pages 195-199.
Crossref
Q. Liu, J. Martinez, J. Hodge & D. Fan. 2018. Encyclopedia of Cardiovascular Research and Medicine. Encyclopedia of Cardiovascular Research and Medicine 214 220 .
D. Fan. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Byambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang & Lars Berglund. (2014) Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African–Americans. Atherosclerosis 235:1, pages 223-229.
Crossref
Debra L. Weinstein, Laura A. Williams, Dawn M. Carlson, Maureen T. Kelly, Kim M. Burns, Carolyn M. Setze, Aditya Lele & James C. Stolzenbach. (2013) A Randomized, Double-Blind Study of Fenofibric Acid Plus Rosuvastatin Compared With Rosuvastatin Alone in Stage 3 Chronic Kidney Disease. Clinical Therapeutics 35:8, pages 1186-1198.
Crossref
William F Keane, Joanne E Tomassini & David R Neff. (2013) Lipid Abnormalities in Patients with Chronic Kidney Disease: Implications for the Pathophysiology of Atherosclerosis. Journal of Atherosclerosis and Thrombosis 20:2, pages 123-133.
Crossref
Hiroyuki Imamura, Keiko Mizuuchi & Reika Oshikata. (2012) Physical Activity and Blood Lipids and Lipoproteins in Dialysis Patients. International Journal of Nephrology 2012, pages 1-6.
Crossref
S Bevc, A Potočnik & R Hojs. (2011) Lipids, Waist Circumference and Body Mass Index in Haemodialysis Patients. Journal of International Medical Research 39:3, pages 1063-1074.
Crossref
Esther M.M. Ooi, Doris T. Chan, Gerald F. Watts, Dick C. Chan, Theodore W.K. Ng, Gursharan K. Dogra, Ashley B. Irish & P. Hugh R. Barrett. (2011) Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease. Journal of Lipid Research 52:4, pages 794-800.
Crossref
Doris T. Chan, Gursharan K. Dogra, Ashley B. Irish, Esther M. Ooi, P. Hugh Barrett, Dick C. Chan & Gerald F. Watts. (2009) Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III. Journal of Lipid Research 50:12, pages 2524-2531.
Crossref
Jeffrey M. Saland & Henry N. Ginsberg. (2007) Lipoprotein metabolism in chronic renal insufficiency. Pediatric Nephrology 22:8, pages 1095-1112.
Crossref
George A. Kaysen. (2007) Disorders in High-Density Metabolism With Insulin Resistance and Chronic Kidney Disease. Journal of Renal Nutrition 17:1, pages 4-8.
Crossref
Sabin Shurraw & Marcello Tonelli. (2020) Statins for Treatment of Dyslipidemia in Chronic Kidney Disease. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26:5, pages 523-539.
Crossref
Elżbieta Kimak, Andrzej Książek & Janusz Solski. (2006) Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure. Clinical Chemistry and Laboratory Medicine (CCLM) 44:1.
Crossref
O. Ukkola & Y. A. Kesaniemi. (2003) Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus. Journal of Internal Medicine 254:4, pages 391-394.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.